ClassID:

21647

A61K2300/00 - page 6 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#1501
20180346535
2018-12-06

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

#1502
20180346445
2018-12-06

Pyrazoline dihydroquinolones, pharmaceutical compositions, and uses

#1503
20180344905
2018-12-06

Drug delivery devices and methods of making and using same

#1504
20180344857
2018-12-06

Analgesic preparation with nanocarriers and use thereof

#1505
20180344855
2018-12-06

Stable Anti-inflammatory Solutions for Injection

#1506
20180344850
2018-12-06

X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments

#1507
20180344824
2018-12-06

Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same

#1508
20180344822
2018-12-06

Composition and therapeutic anti-tumour vaccine

#1509
20180344819
2018-12-06

Compositions and methods for counteracting Factor Xa inhibition

#1510
20180344818
2018-12-06

Agent for use in the case of fructose intolerance

#1511
20180344811
2018-12-06

Methods and compositions for treatment of bone, skin, subcutaneous, mucosal and/or submucosal cancer by percutaneous and/or transmucosal administration of interferon

#1512
20180344810
2018-12-06

Il-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody

#1513
20180344802
2018-12-06

Pharmaceutical formulation for bedwetting and method of use thereof

#1514
20180344801
2018-12-06

METHODS OF TREATING MYELOID LEUKEMIA

#1515
20180344797
2018-12-06

METHODS FOR TREATMENT OF ATHEROSCLEROSIS

#1516
20180344772
2018-12-06

Use of whey protein micelles and polysaccharides for improving insulin profile

#1517
20180344771
2018-12-06

Pharmaceutical kit comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor

#1518
20180344767
2018-12-06

Diagnostic methods for T cell therapy

#1519
20180344761
2018-12-06

Compositions and methods for inducing beige or brown fat tissue

#1520
20180344756
2018-12-06

METHODS FOR THE TREATMENT AND PREVENTION OF RENAL DISORDERS AND FATTY LIVER DISORDERS

#1521
20180344755
2018-12-06

Composition for treating neuropathy, process and method of treatment thereof

#1522
20180344748
2018-12-06

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC INFLAMMATORY DISEASES

#1523
20180344743
2018-12-06

METHODS OF TREATMENT OF ANORECTAL AND GENITAL DISORDERS

#1524
20180344741
2018-12-06

ANTIDIABETIC MEDICATIONS

#1525
20180344740
2018-12-06

Treatment of B-cell malignancies by a combination JAK and PI3K inhibitors

#1526
20180344733
2018-12-06

4,6-pyrimidinylene derivatives and uses thereof

#1527
20180344732
2018-12-06

METHODS FOR REDUCING THE RISK OF AN ADVERSE TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION IN MULTIPLE SCLEROSIS PATIENTS

#1528
20180344727
2018-12-06

COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY

#1529
20180344724
2018-12-06

Combination therapy

#1530
20180344722
2018-12-06

Combination of oxymetazoline and ipratropium in topical nasal application for the treatment of a cough

#1531
20180344721
2018-12-06

Medicinal Treatment of Chronic Inflammatory Dermal Disorders

#1532
20180344718
2018-12-06

METHOD OF TREATING HYPERTENSION

#1533
20180344714
2018-12-06

Topical nifedipine formulations and uses thereof

#1534
20180344709
2018-12-06

Use of gaboxadol in the treatment of tinnitus

#1535
20180344708
2018-12-06

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

#1536
20180344703
2018-12-06

Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system

#1537
20180344699
2018-12-06

ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF CANCER

#1538
20180344697
2018-12-06

Veterinary formulations

#1539
20180344689
2018-12-06

Complex of a glucopyranosyl derivative and preparation method and use thereof

#1540
20180344686
2018-12-06

MICROENCAPSULATED CANNABINOID COMPOSITIONS

#1541
20180344682
2018-12-06

COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC STROKE

#1542
20180344679
2018-12-06

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

#1543
20180344676
2018-12-06

TOPICAL ANALGESIC PAIN RELIEF FORMULATIONS, MANUFACTURE AND METHODS OF USE THEREOF

#1544
20180344673
2018-12-06

PHARMACEUTICAL FORMULATION FOR REDUCING BLADDER SPASMS AND METHOD OF USE THEREOF

#1545
20180344665
2018-12-06

COMPOSITIONS FOR TISSUE STABILIZATION

#1546
20180344661
2018-12-06

Cannabis oil compositions and methods for preparation thereof

#1547
20180344657
2018-12-06

Nanoparticles for treatment of posterior segment ocular diseases and conditions

#1548
20180344647
2018-12-06

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1549
20180344634
2018-12-06

Cannabinoid formulations for inhalation

#1550
20180339983
2018-11-29

BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS

#1551
20180339961
2018-11-29

Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compounds and uses thereof

#1552
20180339095
2018-11-29

METHODS OF ADMINISTERING NITRIC OXIDE TO ARTERIAL OR ARTERIALIZED BLOOD

#1553
20180339061
2018-11-29

Antibodies, pharmaceutical compositions and methods

#1554
20180339047
2018-11-29

Copper-cysteamine and methods of use

#1555
20180339043
2018-11-29

MODIFIED ANTIBODIES

#1556
20180339023
2018-11-29

PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON THERAPY TO BASAL INSULIN

#1557
20180339019
2018-11-29

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

#1558
20180339012
2018-11-29

METHODS FOR TREATMENT OF ATHEROSCLEROSIS

#1559
20180339010
2018-11-29

Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

#1560
20180338988
2018-11-29

Compositions for treating neurological disorders

#1561
20180338983
2018-11-29

Formulations for treatment of post-traumatic stress disorder

#1562
20180338979
2018-11-29

Method of Adjuvant Cancer Treatment

#1563
20180338973
2018-11-29

Pyrimidine derivative and use thereof

#1564
20180338964
2018-11-29

3-(PIPERIDIN-4-YL)-ISOXAZOL-3(OH)-ONES FOR TREATMENT OF DERMATOLOGIC DISORDERS

#1565
20180338956
2018-11-29

COMBINED THERAPY FOR NMDAR ANTAGONIST-RESPONSIVE NEUROPSYCHIATRIC DISORDERS

#1566
20180338953
2018-11-29

Compositions and Methods for Non-Surgical Treatment of Ptosis

#1567
20180338944
2018-11-29

Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof

#1568
20180338943
2018-11-29

POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS

#1569
20180338942
2018-11-29

Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome

#1570
20180338941
2018-11-29

RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

#1571
20180338936
2018-11-29

Methods and Compositions for the Treatment and Prevention of Allergic Rhinitis

#1572
20180338935
2018-11-29

Combination therapy for metastatic cancer

#1573
20180338932
2018-11-29

COMPOSITIONS AND METHODS OF TREATMENT FOR MVID AND RELATED DISEASES

#1574
20180338931
2018-11-29

Use of cannabinoids in the treatment of epilepsy

#1575
20180338917
2018-11-29

Compositions for delivery of drug combinations

#1576
20180338475
2018-11-29

ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS, AND USES THEREOF

#1577
20180334655
2018-11-22

Biologic composition and method of manufacture

#1578
20180334495
2018-11-22

USE OF COMPLEMENT PATHWAY INHIBITORS TO TREAT OCULAR DISEASES

#1579
20180333503
2018-11-22

ANTI-FOLR1 IMMUNOCONJUGATES AND ANTI-PD-1 ANTIBODY COMBINATIONS

#1580
20180333469
2018-11-22

INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVATIVES

#1581
20180333464
2018-11-22

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

#1582
20180333424
2018-11-22

Oxysterol-statin compounds for bone growth

#1583
20180333414
2018-11-22

Ophthalmic compositions and methods of use

#1584
20180333413
2018-11-22

Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide

#1585
20180333406
2018-11-22

BENZONAPTHYRIDINE COMPOSITIONS AND USES THEREOF

#1586
20180333405
2018-11-22

Combination therapy

#1587
20180333401
2018-11-22

METHODS OF TREATING LIVER DISEASE

#1588
20180333398
2018-11-22

METHOD OF WEIGHT REDUCTION

#1589
20180333394
2018-11-22

Compositions and methods employing FtsZ as a target for Albendazole sulfone

#1590
20180333392
2018-11-22

COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM

#1591
20180333389
2018-11-22

VITAMIN E COMPOSITIONS AND METHODS OF USE THEREFOR

#1592
20180333388
2018-11-22

Composition and medical product for reducing body weight and body fat, and use of said product

#1593
20180333387
2018-11-22

Product comprising red clover extract and methods for producing the same

#1594
20180333386
2018-11-22

AGENTS USEFUL FOR TREATING FRIEDREICH'S ATAXIA AND OTHER NEURODEGENERATIVE DISEASES

#1595
20180333385
2018-11-22

Methods for treating cancer

#1596
20180333374
2018-11-22

More potent and less toxic formulations of epinephrine and methods of medical use

#1597
20180333367
2018-11-22

Patches and Methods for the Transdermal Delivery of a Therapeutically Effective Amount of Iron

#1598
20180333360
2018-11-22

Pharmaceutical compositions for treating or preventing pain

#1599
20180327495
2018-11-15

Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic cancers

#1600
20180327450
2018-11-15

AROMATIC-CATIONIC PEPTIDES AND METHODS FOR USING SAME

#1601
20180327443
2018-11-15

Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds

#1602
20180327415
2018-11-15

Crystalline forms of a Bruton's tyrosine kinase inhibitor

#1603
20180327408
2018-11-15

[1,2,4]triazolo[1,5-a]pyrimidin-7-yl compound

#1604
20180327367
2018-11-15

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

#1605
20180327348
2018-11-15

Long-term memory inducing agent

#1606
20180327120
2018-11-15

New A-PRP Medical Device & Tissue Engineering Composition, Manufacturing Machines And Process

#1607
20180326090
2018-11-15

Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use

#1608
20180326066
2018-11-15

Semifluorinated alkane compositions

#1609
20180326059
2018-11-15

Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

#1610
20180326054
2018-11-15

Bispecific antibodies specifically binding to PD1 and LAG3

#1611
20180326052
2018-11-15

Cancer treatment composition combining anti-CD26 antibody and other anticancer agent

#1612
20180326028
2018-11-15

CD200 inhibitors and methods of use thereof

#1613
20180326027
2018-11-15

EPITOPES IN AMYLOID BETA AND CONFORMATIONALLY-SELECTIVE ANTIBODIES THERETO

#1614
20180326022
2018-11-15

COMPOSITIONS AND METHODS FOR IMPROVING HEART FUNCTION AND TREATING HEART FAILURE

#1615
20180326014
2018-11-15

PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF DIABETES

#1616
20180326012
2018-11-15

METHOD FOR TREATING TUMOR BY USING RECOMBINANT INTERFERON WITH CHANGED SPATIAL CONFIGURATION

#1617
20180325996
2018-11-15

Prevention and treatment of ocular side effects with a cyclosporin

#1618
20180325977
2018-11-15

Collagen peptide-based medicament compositions and devices and methods of production and use thereof

#1619
20180325974
2018-11-15

Drug combinations and uses in treating a coughing condition

#1620
20180325946
2018-11-15

Composition for treatment of damaged part

#1621
20180325942
2018-11-15

MULTICOMPONENT ORAL CARE COMPOSITION

#1622
20180325934
2018-11-15

Method of treating bacterial infections

#1623
20180325932
2018-11-15

Compositions comprising decitabine and tetrahydrouridine and uses thereof

#1624
20180325927
2018-11-15

Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors

#1625
20180325926
2018-11-15

Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors

#1626
20180325920
2018-11-15

System and Method for Diagnosis and Treatment

#1627
20180325908
2018-11-15

METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION

#1628
20180325904
2018-11-15

Administration of NEDD8-activating enzyme inhibitor and chemotherapeutic agents

#1629
20180325903
2018-11-15

Therapeutic methods and compositions

#1630
20180325902
2018-11-15

COMPOSITIONS AND METHODS RELATING TO CANCER

#1631
20180325895
2018-11-15

Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy]-N-(methylsulfonyl)acetamide

#1632
20180325894
2018-11-15

COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER

#1633
20180325893
2018-11-15

SUBACUTE ADMINISTRATION OF NMDA MODULATORS ALONE OR IN COMBINATION

#1634
20180325890
2018-11-15

Methods and pharmaceutical compostions for treating rhabdomyolysis

#1635
20180325889
2018-11-15

IMMUNOREGULATORY AGENTS

#1636
20180325884
2018-11-15

METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS

#1637
20180325883
2018-11-15

Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

#1638
20180325881
2018-11-15

Methods for treatment of Fabry disease

#1639
20180325877
2018-11-15

Use of maleimide derivatives for preventing and treating cancer

#1640
20180325863
2018-11-15

Antimicrobial compositions for

#1641
20180325860
2018-11-15

Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase

#1642
20180325855
2018-11-15

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#1643
20180325854
2018-11-15

USE OF PROTEASOME INHIBITORS TO TREAT OCULAR DISORDERS

#1644
20180325853
2018-11-15

BENZOQUINONE DERIVATIVE E3330 IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF COLON CANCER

#1645
20180325851
2018-11-15

Transdermally-delivered combination drug therapy for pain

#1646
20180325846
2018-11-15

PHARMACEUTICAL FORMULATION FOR REDUCING FREQUENCY OF URINATION AND METHOD OF USE THEREOF

#1647
20180325844
2018-11-15

Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms

#1648
20180325829
2018-11-15

Millicapsule formulations comprising polyunsaturated free fatty acids

#1649
20180325826
2018-11-15

Uses of milrinone controlled-release formulation

#1650
20180325816
2018-11-15

Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

#1651
20180325815
2018-11-15

Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

#1652
20180325781
2018-11-15

Formulations for controlled release of bupivacaine

#1653
20180325157
2018-11-15

A DIETARY SUPPLEMENT COMPRISING BETA-GLUCAN AND CASEIN HYDROLSATE FOR IMPROVING HEALTH AND GROWTH PERFORMANCE IN A MAMMAL

#1654
20180321255
2018-11-08

Soluble MANF in pancreatic beta-cell disorders

#1655
20180319865
2018-11-08

Identification of Novel Small Molecule Beta2 Integrin Agonists

#1656
20180319856
2018-11-08

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

#1657
20180319806
2018-11-08

Crystalline forms of a bruton's tyrosine kinase inhibitor

#1658
20180319805
2018-11-08

CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR

#1659
20180319788
2018-11-08

N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway

#1660
20180319783
2018-11-08

Ferroportin inhibitors

#1661
20180319771
2018-11-08

Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

#1662
20180319749
2018-11-08

Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases

#1663
20180319748
2018-11-08

Kinase inhibitors

#1664
20180318469
2018-11-08

Composition comprising hyaluronic acid and mepivacaine

#1665
20180318448
2018-11-08

Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemia

#1666
20180318444
2018-11-08

Glypican 2 as a cancer marker and therapeutic target

#1667
20180318442
2018-11-08

Formulation of nanostructured gels for increased agent loading and adhesion

#1668
20180318421
2018-11-08

Methods for the treatment of recurrent glioblastoma (RGBM)

#1669
20180318404
2018-11-08

Compositions and methods for treatment of homocystinuria

#1670
20180318402
2018-11-08

COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS

#1671
20180318389
2018-11-08

NMDAR antagonists for the treatment of diseases associated with angiogenesis

#1672
20180318388
2018-11-08

Compositions and methods for sensitizing low responsive tumors to cancer therapy

#1673
20180318386
2018-11-08

PEPTIDES AND METHODS OF TREATING ENDOMETRIOSIS USING THE SAME

#1674
20180318382
2018-11-08

Therapy and kit for the prevention and treatment of cystic fibrosis

#1675
20180318376
2018-11-08

Multidimensional approach for Cancer treatment

#1676
20180318369
2018-11-08

Transfer factor preparations and associated methods

#1677
20180318361
2018-11-08

Honey-cannabinoid therapeutic composition

#1678
20180318355
2018-11-08

METHODS AND COMPOSITIONS FOR IMPROVED TISSUE REGENERATION BY SUPPRESION OF INTERFERIN-GAMMA AND TUMOR NECROSIS FACTOR-ALPHA

#1679
20180318354
2018-11-08

Mesenchymal stem cell-derived exosomes and their uses

#1680
20180318347
2018-11-08

METHODS FOR TREATING CANCER

#1681
20180318345
2018-11-08

Methods of inhibiting the virulence of a pathogen with an oxidized tannin to treat a gastrointestinal spasm

#1682
20180318334
2018-11-08

DRUG CONTAINING CATIONIZED CHITOSAN

#1683
20180318333
2018-11-08

Composition based on xyloglucan and proteins for the treatment of intestinal disorders

#1684
20180318329
2018-11-08

Compositions and methods of treating acne and photoaging

#1685
20180318328
2018-11-08

Therapy for inhibition of single-stranded RNA virus replication

#1686
20180318324
2018-11-08

ANTI-AGING COMPOSITIONS AND METHODS FOR USING SAME

#1687
20180318316
2018-11-08

Dosing regimen for sedation with CNS 7056 (Remimazolam)

#1688
20180318314
2018-11-08

ANTITUMOR AGENT

#1689
20180318313
2018-11-08

Treatments for resistant acne

#1690
20180318306
2018-11-08

METHODS OF TREATING TRANSPLANT REJECTION

#1691
20180318305
2018-11-08

COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES

#1692
20180318289
2018-11-08

TREATMENTS FOR DEPRESSION AND OTHER DISEASES WITH A LOW DOSE AGENT

#1693
20180318288
2018-11-08

Glutamate agents in the treatment of mental disorders

#1694
20180318287
2018-11-08

Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer

#1695
20180318283
2018-11-08

Pharmaceutical composition, use of mefloquine in fixed dose, and method for treating tuberculosis

#1696
20180318275
2018-11-08

COMBINATION THERAPY USING PI3K INHIBITOR AND MDM2 INHIBITOR

#1697
20180318267
2018-11-08

METHOD FOR IMPROVING PHARMACOKINETICS

#1698
20180318264
2018-11-08

Ophthalmic pharmaceutical compositions and uses relating thereto

#1699
20180318261
2018-11-08

Use of composition for preparing a medicament for treatment of amyotrophic lateral sclerosis

#1700
20180318257
2018-11-08

PDE4 modulators for treating and preventing immune reconstitution inflammatory syndrome (IRIS)

#1701
20180318251
2018-11-08

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1702
20180318244
2018-11-08

Modified release orally administered amino acid formulations

#1703
20180318241
2018-11-08

TREATMENT OF NERVOUS SYSTEM DISORDERS USING THYROID HORMONE NEUTRAL DOSES OF RXR AGONISTS

#1704
20180318235
2018-11-08

Zeaxanthin for Tumor Treatment

#1705
20180318234
2018-11-08

PURGATIVE COMPOSITION FOR CLEANSING INTESTINAL TRACT

#1706
20180318170
2018-11-08

Inhalable Pharmaceutical Compositions

#1707
20180316309
2018-11-01

SNS-595 AND METHODS OF USING THE SAME

#1708
20180312806
2018-11-01

Inhibition of innate immune response

#1709
20180312559
2018-11-01

METHODS FOR TREATING REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS

#1710
20180312556
2018-11-01

Compositions and methods for ceramide-elevating therapeutic strategies

#1711
20180312524
2018-11-01

Benzopiperazine compositions as BET bromodomain inhibitors

#1712
20180312474
2018-11-01

KDM1A inhibitors for the treatment of disease

#1713
20180311376
2018-11-01

A Medical Composition and a Medical Hydrogel for Use in the Prevention and/or Treatment of a Disease of the Facet Joints and/or for Use in the Replacement and/or Regeneration of Articular Facets

#1714
20180311361
2018-11-01

Compositions

#1715
20180311355
2018-11-01

Methods for radiotherapy to trigger light activation drugs

#1716
20180311331
2018-11-01

PROGNOSIS AND TREATMENT OF SQUAMOUS CELL CARCINOMAS

#1717
20180311325
2018-11-01

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

#1718
20180311316
2018-11-01

INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5

#1719
20180311314
2018-11-01

Glucokinase activator compositions for the treatment of diabetes

#1720
20180311313
2018-11-01

Composition having tissue-repairing activity, and use therefor

#1721
20180311308
2018-11-01

METHODS OF TREATING MYELOID LEUKEMIA

#1722
20180311306
2018-11-01

METHODS FOR TREATING HYPOTENSION

#1723
20180311297
2018-11-01

PHARMACEUTICAL COMPOSITION FOR INCREASING CONTENT AND AVAILABILITY OF CYCLIC ADENOSINE MONOPHOSPHATE IN A BODY AND PREPARATION THEREOF

#1724
20180311288
2018-11-01

Bioeffective krill oil compositions

#1725
20180311281
2018-11-01

Primed muscle progenitor cells and uses thereof

#1726
20180311274
2018-11-01

IN SITU NEUTRALIZATION COMPOSITION

#1727
20180311272
2018-11-01

Compositions and methods for treating joints

#1728
20180311263
2018-11-01

Methods for treating Filoviridae virus infections

#1729
20180311261
2018-11-01

Methods of treating advanced prostate cancer

#1730
20180311256
2018-11-01

METHOD OF TREATING PATIENTS COADMINISTERED A FACTOR Xa INHIBITOR AND VERAPAMIL

#1731
20180311249
2018-11-01

Combination therapy for treating malignancies

#1732
20180311245
2018-11-01

USE OF A COMBINATIONAL THERAPY OF LSD1 INHIBITORS WITH CDK2 INHIBITORS IN THE TREATMENT OF CANCER

#1733
20180311241
2018-11-01

PHARMACEUTICAL SYNERGISTIC COMBINATION

#1734
20180311238
2018-11-01

Selective Agonist Of a6 Containing nAChRs

#1735
20180311233
2018-11-01

Pharmaceutical combination of opioid and prostaglandin compound

#1736
20180311232
2018-11-01

Triple combination

#1737
20180311231
2018-11-01

DESETHYLHYDROXYCHLOROQUINE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH INFLAMMATION

#1738
20180311230
2018-11-01

USE OF LAQUINIMOD TO DELAY HUNTINGTON'S DISEASE PROGRESSION

#1739
20180311227
2018-11-01

Pharmaceutical composition and uses thereof

#1740
20180311225
2018-11-01

EXTERNAL PREPARATION

#1741
20180311220
2018-11-01

TREATMENT OF CANCERS WITH ACQUIRED RESISTANCE TO KIT INHIBITORS

#1742
20180311217
2018-11-01

METHODS OF TREATMENT AND COMPOSITIONS WITH XANTHINE OXIDASE INHIBITORS

#1743
20180311216
2018-11-01

Pharmaceutical Composition Comprising Deferasirox

#1744
20180311205
2018-11-01

Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity

#1745
20180311199
2018-11-01

COMBINATION TREATMENT FOR INFLAMMATORY DISEASES

#1746
20180311198
2018-11-01

Composition of chlorogenic acid and methods of making and using the same in treating serum lipid levels

#1747
20180311197
2018-11-01

Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients

#1748
20180311191
2018-11-01

NEW COMBINATION THERAPIES FOR TREATING NEUROLOGICAL DAMAGE

#1749
20180311188
2018-11-01

Anti-fungal compositions for treating nails and methods for fabricating and using thereof

#1750
20180311186
2018-11-01

PHARMACEUTICAL FORMULATION FOR BEDWETTING AND METHOD OF USE THEREOF

#1751
20180311170
2018-11-01

Pharmaceutical composition containing clomipramine and preparation method therefor

#1752
20180311148
2018-11-01

Multiphasic compositions

#1753
20180310605
2018-11-01

INFANT FORMULA WITH MILK FAT FOR PROMOTING HEALTHY GROWTH

#1754
20180306796
2018-10-25

Methods and compositions relating to proteasome inhibitor resistance

#1755
20180305676
2018-10-25

Bacterial toxins and uses thereof as Ras specific proteases for treating cell proliferation diseases and disorders

#1756
20180305365
2018-10-25

Pharmaceutical compositions of compound

#1757
20180305360
2018-10-25

COMT inhibiting methods and compositions

#1758
20180305359
2018-10-25

Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors

#1759
20180305351
2018-10-25

6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors

#1760
20180305345
2018-10-25

COMPOSITIONS AND METHODS FOR ENHANCING ONCOLYTIC VIRUS EFFICACY

#1761
20180305311
2018-10-25

Synergistic compositions

#1762
20180305305
2018-10-25

2-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using same

#1763
20180303948
2018-10-25

Polymer conjugate comprising a bioactive agent

#1764
20180303935
2018-10-25

A NANOMATERIAL COMPLEX COMPRISING GRAPHENE OXIDE ASSOCIATED WITH A THERAPEUTIC AGENT AND METHODS OF USE

#1765
20180303922
2018-10-25

Regulatory T cell PD-1 modulation for regulating T cell effector immune responses

#1766
20180303905
2018-10-25

Use of immunomodulatory kits for immunotherapeutic treatment of patients with myeloid leukemias

#1767
20180303901
2018-10-25

Notch1 Decoy Antagonists Protect From Obesity-Induced Insulin Resistance and Fatty Liver

#1768
20180303900
2018-10-25

HU specific interfering agents

#1769
20180303891
2018-10-25

Specific nutritional or therapeutic agent including a mixture of grape and blueberry

#1770
20180303889
2018-10-25

Composition for prevention, alleviation, or treatment of peripheral neuropathy comprising Lithospermi Radix extract as an effective component

#1771
20180303878
2018-10-25

TREATMENT FOR INFECTION COMPOSED OF MENSTRUAL STEM CELLS

#1772
20180303874
2018-10-25

Compositions and Methods for the Prevention of Microbial Infections

#1773
20180303869
2018-10-25

Methods of using ophthalmic compositions comprising povidone-iodine

#1774
20180303863
2018-10-25

Pharmaceutical Composition for Treating STK11-Mutation Cancer Using Cardiac Glycosides

#1775
20180303856
2018-10-25

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#1776
20180303854
2018-10-25

Effervescent formulation based on pyridoxal-5-phosphate

#1777
20180303847
2018-10-25

Pharmaceutical compositions and methods for anesthesiological applications

#1778
20180303846
2018-10-25

BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES

#1779
20180303843
2018-10-25

Controlled-release tozadenant formulations

#1780
20180303840
2018-10-25

Combination therapy for treating malignancies

#1781
20180303838
2018-10-25

TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION

#1782
20180303837
2018-10-25

THERAPEUTIC REGIMEN

#1783
20180303830
2018-10-25

CANCERS EXPRESSING CCR5 AND METHODS OF TREATMENT OF SAME

#1784
20180303818
2018-10-25

COMPOSITIONS COMPRISING NICOTINIC AGONISTS AND METHODS OF USING SAME

#1785
20180303815
2018-10-25

Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer

#1786
20180303814
2018-10-25

METHODS AND COMPOSITIONS FOR ENHANCING FEMALE SEXUAL AROUSAL AND TREATING FEMALE SEXUAL DYSFUNCTION

#1787
20180303806
2018-10-25

Dosage and formulation

#1788
20180303804
2018-10-25

Methods of treating hepatic encephalopathy

#1789
20180303801
2018-10-25

UNIT ORAL SOLID DOSE COMPOSITIONS COMPOSED OF IBUPROFEN AND NIZATIDINE

#1790
20180303800
2018-10-25

SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS

#1791
20180303793
2018-10-25

METHODS AND COMPOSITIONS FOR TREATING TRAUMATIC BRAIN INJURY

#1792
20180303788
2018-10-25

Entacapone for treatment of obesity

#1793
20180303784
2018-10-25

Omega-3 compositions, dosage forms, and methods of use

#1794
20180303783
2018-10-25

Compositions and methods for treating retinopathy

#1795
20180303779
2018-10-25

Methods of reducing risk of cardiovascular disease

#1796
20180303778
2018-10-25

Supporting immunomodulatory agent

#1797
20180303773
2018-10-25

Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2O2 level in cancer cells of a subject

#1798
20180303771
2018-10-25

Intravenous administration of tramadol

#1799
20180303769
2018-10-25

Inhibition of multiple pathogenic agents using bithionol

#1800
20180303768
2018-10-25

Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity